title: [Limited prescribing freedom by federal cost regulation?].
abstract: The governmental budgeting of the overall expenses for medicines obviously does not impair the quality of medical treatment. But pharmaco-epidemiologic investigations are lacking. This regulation is just an instrument for diminution the health care expenses without interfering with the quality of prescription and provision of medicines.
authors.affiliation: Arzneimittelkommission der deutschen Arzteschaft, Köln.
authors.forename: R
authors.initials: R
authors.lastname: Lasek
mesh_terms: D017046:Cost Savings / Q000331:legislation & jurisprudence; D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence*; D016527:Drug Costs / Q000331:legislation & jurisprudence*; D011307:Drug Prescriptions / Q000191:economics*; D005858:Germany; D006801:Humans; D009313:National Health Programs / Q000191:economics / Q000331:legislation & jurisprudence*
vernacular_title: Einschränkung der Verordnungsfreiheit durch die Festbetragsregelung?